OptimizeRx Corp
OPRX- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- SEC CIK
- 0001448431
No open-market purchases or sales by OptimizeRx Corp insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $64.2M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding OptimizeRx Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 97 | 1 | 92 | −4 |
| Shares | 12.8M | 314.5K | 13.1M | +614.5K (+4.9%) |
| Value | $155.4M | $3.82M | $130.8M | −$20.7M (−13.7%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held OptimizeRx Corp at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Asset Management Americas Inc | 310,000 | $3.10M | 0.00% |
| Credit Agricole S A | 89,200 | $892.0K | 0.01% |
| Marshall Wace, LLP | 45,748 | $457.5K | 0.00% |
| Squarepoint Ops LLC | 28,153 | $281.5K | 0.00% |
| Campbell & CO Investment Adviser LLC | 25,813 | $258.1K | 0.02% |
| Quadrature Capital Ltd | 17,732 | $177.5K | 0.00% |
| Bank of Montreal | 14,102 | $156.1K | 0.00% |
| Corebridge Financial, Inc. | 9,451 | $94.5K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $81.3K | 0.00% |
| Clear Street Markets LLC | 2,504 | $25.0K | 0.01% |
| Redwood Wealth Management Group, LLC | 1,750 | $17.5K | 0.01% |
| Huntington National Bank | 1,325 | $13.3K | 0.00% |
| Jones Financial Companies LLLP | 760 | $7.60K | 0.00% |
| nVerses Capital, LLC | 200 | $2.00K | 0.00% |
| Quest Partners LLC | 61 | $610 | 0.00% |
| Innealta Capital, LLC | 1 | $10 | 0.00% |
| GAMMA Investing LLC | 1 | $10 | 0.00% |
| CWM, LLC | 5 | $0 | 0.00% |
Sold out (22)
Institutions that held OptimizeRx Corp at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held OptimizeRx Corp at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 314,466 | $3.82M |